To bring innovation and hope to the treatment of infectious diseases requires focus and commitment.
Already established as a leader in the fields of Transplantation and Urology, Astellas has also been applying its technical expertise and experience to Anti-infective agents. With active R&D programmes advancing therapies for serious fungal and bacterial infections, we will continue our commitment to this field as we strive to deliver pioneering treatments to address the evolving needs in this complex area. We trust that you will get to know us better as we work together to help provide patients with a brighter tomorrow.
NPR17018Ukb – June 2018
Learn more about our therapy areas:
Well established therapies to prevent organ rejection after transplantation
Leading research to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections